Our Workig Best Processs
Explane Projects
Explane Projects many varios
suffered alten in some
Generate Proposal
Testing Begins many varios suffered alten in some
Testing Begins
There are many varios passages
suffered alten in some
Reports Delivered
Reports Delivered many varios suffered alten in some
Explore Our Main Service
Chemical Research
Chemical Research is simply dummy text of the printing infancy and typesetting industry text Lorem Ipsum has been.
Pathology Testing
Chemical Research is simply dummy text of the printing infancy and typesetting industry text Lorem Ipsum has been.
Chemical Formula
Chemical Research is simply dummy text of the printing infancy and typesetting industry text Lorem Ipsum has been.
Expert Team
Alex Jhon Martin
Cytogeneticist
Alexa Jhon
Pathology Assistant
Naidan Smith
Histotechnologist
Danial Frankie
Histologic technician
Danial Frankie
PhlebotomistBest Truse Experts Laboratory Technlogy
Dr. John Deo
Laboratory Managers
see Our Latest Blog
Muse Microscopy, Inc. to Present SmartPath MUSE Technology™ (SmartPath) at Upcoming Emerging Medtech Summit (LSI USA ’24) in Dana Point, CA
IRVINE, Calif., March 6, 2024 /PRNewswire/ — Muse Microscopy, Inc., a wholly-owned subsidiary of Smart Health Diagnostics Company, is developing a slide-free diagnostic imaging platform designed to transform the patient’s experience by providing the ability to generate digital tissue images within minutes to send to the pathologist for an immediate read. Larry Dentice, the President and Director […]
SmartPath Dx is Changing Pathology Image by Image, Minute by Minute – SmartHealth Dx announces the unveiling of SmartPath Dx at Octane’s Medical Innovation Forum
IRVINE, Calif., October 25, 2023 /PRNewswire/ — Smart Health Diagnostics Company (“SHDx” or “the Company”), a developer of precision diagnostic tests and imaging technologies that address unmet clinical needs for advancing today’s standards of care, today announced its upcoming participation in Octane’s Medical Innovation Forum 2023 to discuss SmartPath Dx’s impact on human health in the pathology […]
SmartHealth Dx Featured in Cover Story of Med Tech Outlook Magazine’s Pathology Special Edition
IRVINE, Calif., June 13, 2023 /PRNewswire/ — Smart Health Diagnostics Company (“SHDx” or “the Company”), a developer of precision diagnostic tests that address unmet clinical needs in pathology and vascular inflammation for advancing today’s standards of care, announced that CEO and Chairman Mitch Levine is featured in the June 8, 2023 edition of Med Tech […]
SmartHealth Diagnostics Appoints Accomplished Corporate and Finance Leader Mitch Levine as President, Chief Financial Officer, and Director
Highly regarded diagnostics industry executive and capital markets expert to guide planned growth and value creation for evolutionary data-to-diagnostics platform company